This article investigates whether qualitative information provided by banks about risk appetite (RA) sheds substantive insight on their effective risk taking (RT) and whether this latter in turn affects RA disclosure, as well as the role played by specific types of banks' reports (i.e., integrated report, annual report, Pillar 3 report) on such relations. Using a sample of 134 reports representing 52 banks, a generalized structural equation model is applied. The article hypothesizes and empirically finds a reciprocal relation between RA disclosure and banks' RT. More specifically, in line with agency theory, the analysis displays a predominance of the inverse relation according to which banks showing higher RT provide greater disclosure. In addition, RT is found to play a mediator role between the adoption of a specific type of report-the integrated report-and RA disclosure, independently of the context in which the banks operate. Results also highlight that RT in banks adopting an integrated report is lower than the one of matched banks. Overall, this study extends risk science by complementing the literature stream on banks' accounting discretion and risk disclosure, supporting the impact of market discipline in promoting new forms of corporate reporting. Results indeed emphasize the key role of integrated reporting on RT, suggesting that integrated logic should be strengthened by policy makers to curb banks' excessive RT and leading them to provide substantive disclosure.

Download full-text PDF

Source
http://dx.doi.org/10.1111/risa.13776DOI Listing

Publication Analysis

Top Keywords

risk appetite
8
key role
8
role integrated
8
integrated report
8
integrated
6
banks
6
disclosure
6
risk
5
bank risk
4
appetite communication
4

Similar Publications

Lower back pain (LBP) is a common condition affecting primarily populations in developed countries, placing a significant burden on public health systems around the world. A high rate of pain recurrence increases the risk of developing a chronic syndrome and the occurrence of complex psychosocial and professional problems. Symptoms lasting longer than 12 weeks are associated with the risk of sleep problems, depression, and anxiety.

View Article and Find Full Text PDF

: Previous studies suggest that there is a genetically determined component of fat oxidation at rest and during exercise. To date, the gene has been proposed as a candidate gene to affect fat oxidation during exercise because of the association of the "at-risk" A allele with different obesity-related factors such as increased body fat, higher appetite and elevated insulin and triglyceride levels. The A allele of the gene may also be linked to obesity through a reduced capacity for fat oxidation during exercise, a topic that remains largely underexplored in the current literature.

View Article and Find Full Text PDF

Converging lines of research indicate that inhibitory control is likely to be compromised in contexts that place competing demands on emotional, motivational, and cognitive systems, potentially leading to damaging impulsive behavior. The objective of this study was to identify the neural impact of three challenging contexts that typically compromise self-regulation and weaken impulse control. Participants included 66 healthy adults (M/SD = 29.

View Article and Find Full Text PDF

Purpose Of Review: The present review describes the available literature on the physiologic mechanisms that modulate hunger, appetite, satiation, and satiety with a particular focus on well-established and emerging factors involved in the classic satiety cascade model.

Recent Finding: Obesity is a significant risk factor for numerous chronic conditions like cancer, cardiovascular diseases, and diabetes. As excess energy intake is considered by some to be the primary driver of weight gain, tremendous collective effort should be directed toward reducing excessive feeding at the individual and population levels.

View Article and Find Full Text PDF

Background: Mirtazapine is used to treat depression worldwide, and the effects of mirtazapine on depression rating scales are well-known. Our primary objective was to assess the risks of adverse events with mirtazapine for major depressive disorder.

Methods: We searched relevant sources from inception to 7 March 2024 for randomised clinical trials comparing mirtazapine versus placebo in adults with major depressive disorder.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!